NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50474-781-87 | 50474-781 | HUMAN PRESCRIPTION DRUG | Bimzelx | bimekizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20231017 | N/A | BLA | BLA761151 | UCB, Inc. | BIMEKIZUMAB | 160 mg/mL | 2 SYRINGE, GLASS in 1 CARTON (50474-781-87) / 1 mL in 1 SYRINGE, GLASS |
50474-781-85 | 50474-781 | HUMAN PRESCRIPTION DRUG | Bimzelx | bimekizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20231017 | N/A | BLA | BLA761151 | UCB, Inc. | BIMEKIZUMAB | 160 mg/mL | 2 SYRINGE, GLASS in 1 CARTON (50474-781-85) / 1 mL in 1 SYRINGE, GLASS |
50474-780-79 | 50474-780 | HUMAN PRESCRIPTION DRUG | Bimzelx | bimekizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20231017 | N/A | BLA | BLA761151 | UCB, Inc. | BIMEKIZUMAB | 160 mg/mL | 2 SYRINGE, GLASS in 1 CARTON (50474-780-79) / 1 mL in 1 SYRINGE, GLASS |